Venbio Select Advisor Has Lowered Its Veracyte (VCYT) Holding by $1.11 Million as Shares Declined; Phocas Financial Lowered Its Stake in Myr Group (MYRG) by $309,365

May 26, 2018 - By Winifred Garcia

Veracyte, Inc. (NASDAQ:VCYT) Logo

Venbio Select Advisor Llc decreased its stake in Veracyte Inc (VCYT) by 19.69% based on its latest 2017Q4 regulatory filing with the SEC. Venbio Select Advisor Llc sold 184,454 shares as the company’s stock declined 14.59% with the market. The institutional investor held 752,455 shares of the health care company at the end of 2017Q4, valued at $4.91M, down from 936,909 at the end of the previous reported quarter. Venbio Select Advisor Llc who had been investing in Veracyte Inc for a number of months, seems to be less bullish one the $257.60M market cap company. The stock decreased 2.98% or $0.23 during the last trading session, reaching $7.5. About 62,570 shares traded. Veracyte, Inc. (NASDAQ:VCYT) has declined 39.30% since May 26, 2017 and is downtrending. It has underperformed by 50.85% the S&P500.

Phocas Financial Corp decreased its stake in Myr Group Inc (MYRG) by 4.14% based on its latest 2017Q4 regulatory filing with the SEC. Phocas Financial Corp sold 8,839 shares as the company’s stock declined 14.11% with the market. The institutional investor held 204,479 shares of the basic industries company at the end of 2017Q4, valued at $7.31M, down from 213,318 at the end of the previous reported quarter. Phocas Financial Corp who had been investing in Myr Group Inc for a number of months, seems to be less bullish one the $633.98M market cap company. The stock increased 0.68% or $0.26 during the last trading session, reaching $38.43. About 34,442 shares traded. MYR Group Inc. (NASDAQ:MYRG) has declined 22.82% since May 26, 2017 and is downtrending. It has underperformed by 34.37% the S&P500.

Analysts await Veracyte, Inc. (NASDAQ:VCYT) to report earnings on July, 30. They expect $-0.26 earnings per share, down 18.18% or $0.04 from last year’s $-0.22 per share. After $-0.27 actual earnings per share reported by Veracyte, Inc. for the previous quarter, Wall Street now forecasts -3.70% EPS growth.

Venbio Select Advisor Llc, which manages about $380.08M and $1.54 billion US Long portfolio, upped its stake in Ascendis Pharma by 44,900 shares to 1.68 million shares, valued at $67.34 million in 2017Q4, according to the filing. It also increased its holding in Assembly Biosciences Inc (NASDAQ:ASMB) by 161,372 shares in the quarter, for a total of 1.07 million shares, and has risen its stake in Horizon Pharma Plc (NASDAQ:HZNP).

Investors sentiment decreased to 1.23 in Q4 2017. Its down 0.53, from 1.76 in 2017Q3. It is negative, as 15 investors sold VCYT shares while 16 reduced holdings. 12 funds opened positions while 26 raised stakes. 21.45 million shares or 4.52% less from 22.46 million shares in 2017Q3 were reported. Renaissance Technologies Ltd has invested 0% in Veracyte, Inc. (NASDAQ:VCYT). Grp Inc One Trading LP has 0% invested in Veracyte, Inc. (NASDAQ:VCYT). Broadfin Cap Limited Liability Co stated it has 0.8% in Veracyte, Inc. (NASDAQ:VCYT). Barclays Public Lc holds 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT) for 3,758 shares. Art Advsrs Limited Com has 0% invested in Veracyte, Inc. (NASDAQ:VCYT). Citigroup accumulated 3,461 shares. Invesco Limited holds 11,636 shares. Legal General Gru Public Limited Liability Corp reported 0% stake. Goldman Sachs invested 0% of its portfolio in Veracyte, Inc. (NASDAQ:VCYT). Janney Montgomery Scott Lc holds 11,100 shares or 0% of its portfolio. 61,164 are owned by Bank & Trust Of America De. Rhumbline Advisers holds 0% or 20,367 shares in its portfolio. Tower Research Cap Lc (Trc) owns 0.01% invested in Veracyte, Inc. (NASDAQ:VCYT) for 13,015 shares. Moreover, Product Ltd Liability has 0.01% invested in Veracyte, Inc. (NASDAQ:VCYT) for 48,570 shares. Cannell Ltd Liability holds 1.91 million shares or 3.63% of its portfolio.

More notable recent Veracyte, Inc. (NASDAQ:VCYT) news were published by: Benzinga.com which released: “38 Biggest Movers From Yesterday” on May 23, 2018, also Globenewswire.com with their article: “Research Report Identifies Altair Engineering, Safety Insurance Group, Tyler Technologies, Veracyte, Enviva Partners …” published on May 01, 2018, Seekingalpha.com published: “Veracyte’s (VCYT) CEO Bonnie Anderson on Q1 2018 Results – Earnings Call Transcript” on May 02, 2018. More interesting news about Veracyte, Inc. (NASDAQ:VCYT) were released by: Seekingalpha.com and their article: “Veracyte, Inc. 2018 Q1 – Results – Earnings Call Slides” published on May 02, 2018 as well as Seekingalpha.com‘s news article titled: “Key events next week – healthcare” with publication date: May 11, 2018.

Among 6 analysts covering Veracyte (NASDAQ:VCYT), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Veracyte had 12 analyst reports since August 14, 2015 according to SRatingsIntel. The stock of Veracyte, Inc. (NASDAQ:VCYT) has “Neutral” rating given on Tuesday, November 7 by Janney Capital. BTIG Research maintained the stock with “Buy” rating in Friday, August 14 report. As per Friday, August 14, the company rating was maintained by Piper Jaffray. Cantor Fitzgerald initiated Veracyte, Inc. (NASDAQ:VCYT) rating on Friday, December 18. Cantor Fitzgerald has “Buy” rating and $13.0 target. The stock of Veracyte, Inc. (NASDAQ:VCYT) earned “Outperform” rating by Leerink Swann on Tuesday, November 7. Piper Jaffray downgraded the shares of VCYT in report on Tuesday, November 7 to “Hold” rating. Piper Jaffray maintained Veracyte, Inc. (NASDAQ:VCYT) rating on Wednesday, April 18. Piper Jaffray has “Hold” rating and $4.9000 target. The rating was upgraded by Janney Capital to “Buy” on Tuesday, November 29.

Investors sentiment decreased to 0.81 in 2017 Q4. Its down 0.42, from 1.23 in 2017Q3. It worsened, as 17 investors sold MYRG shares while 50 reduced holdings. 18 funds opened positions while 36 raised stakes. 14.13 million shares or 3.76% more from 13.62 million shares in 2017Q3 were reported. 100,395 are owned by Aqr Cap Mngmt Ltd Liability. Morgan Dempsey Capital Mngmt Ltd owns 0.45% invested in MYR Group Inc. (NASDAQ:MYRG) for 39,172 shares. Barclays Public Limited Com reported 6,834 shares or 0% of all its holdings. Tygh Cap Mgmt holds 0.75% or 110,929 shares in its portfolio. Fisher Asset Mgmt holds 113,081 shares. Invest Counselors Of Maryland Ltd accumulated 660,213 shares. X Mngmt Limited Liability owns 0% invested in MYR Group Inc. (NASDAQ:MYRG) for 2,030 shares. Public Employees Retirement System Of Ohio has invested 0% in MYR Group Inc. (NASDAQ:MYRG). Paradigm Cap Mngmt Ny invested in 0.02% or 8,000 shares. Fincl Bank Of Montreal Can holds 0% in MYR Group Inc. (NASDAQ:MYRG) or 830 shares. State Teachers Retirement System holds 0% or 7,158 shares. 10,138 are owned by Pub Sector Pension Inv Board. Ameritas Inv Partners Inc holds 0% or 1,170 shares. State Common Retirement Fund holds 0% of its portfolio in MYR Group Inc. (NASDAQ:MYRG) for 30,396 shares. The Pennsylvania-based Federated Pa has invested 0% in MYR Group Inc. (NASDAQ:MYRG).

Phocas Financial Corp, which manages about $1.01B and $1.19 billion US Long portfolio, upped its stake in Dime Cmnty Bancshares Inc (NASDAQ:DCOM) by 197,800 shares to 254,489 shares, valued at $5.33 million in 2017Q4, according to the filing. It also increased its holding in Nexstar Broadcasting (NASDAQ:NXST) by 70,239 shares in the quarter, for a total of 228,604 shares, and has risen its stake in Diplomat Pharmacy Inc (NYSE:DPLO).

Analysts await MYR Group Inc. (NASDAQ:MYRG) to report earnings on August, 1. They expect $0.43 EPS, up 514.29% or $0.36 from last year’s $0.07 per share. MYRG’s profit will be $7.09M for 22.34 P/E if the $0.43 EPS becomes a reality. After $0.29 actual EPS reported by MYR Group Inc. for the previous quarter, Wall Street now forecasts 48.28% EPS growth.

Since March 16, 2018, it had 0 insider buys, and 6 insider sales for $3.05 million activity. 39,601 MYR Group Inc. (NASDAQ:MYRG) shares with value of $1.39 million were sold by KOERTNER WILLIAM A.

Among 10 analysts covering MYR Group (NASDAQ:MYRG), 3 have Buy rating, 0 Sell and 7 Hold. Therefore 30% are positive. MYR Group had 31 analyst reports since August 11, 2015 according to SRatingsIntel. Robert W. Baird maintained it with “Buy” rating and $3900 target in Monday, April 9 report. Maxim Group maintained the stock with “Buy” rating in Friday, August 5 report. The company was downgraded on Tuesday, August 11 by Zacks. The rating was maintained by Stifel Nicolaus with “Hold” on Wednesday, October 18. The stock has “Buy” rating by Robert W. Baird on Wednesday, December 6. Robert W. Baird maintained the shares of MYRG in report on Thursday, March 8 with “Outperform” rating. Oppenheimer downgraded MYR Group Inc. (NASDAQ:MYRG) rating on Monday, March 12. Oppenheimer has “Hold” rating and $37.0 target. FBR Capital maintained MYR Group Inc. (NASDAQ:MYRG) rating on Friday, November 6. FBR Capital has “Mkt Perform” rating and $25 target. The stock has “Hold” rating by Stifel Nicolaus on Sunday, December 10. The stock of MYR Group Inc. (NASDAQ:MYRG) earned “Outperform” rating by Robert W. Baird on Friday, November 3.

More recent MYR Group Inc. (NASDAQ:MYRG) news were published by: Benzinga.com which released: “37 Stocks Moving In Thursday’s Mid-Day Session” on May 03, 2018. Also Seekingalpha.com published the news titled: “MYR Group’s (MYRG) CEO Richard Swartz on Q1 2018 Results – Earnings Call Transcript” on May 03, 2018. Globenewswire.com‘s news article titled: “MYR Group Inc. Announces First-Quarter 2018 Results” with publication date: May 02, 2018 was also an interesting one.

MYR Group Inc. (NASDAQ:MYRG) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>